PL377221A1 - Pochodne 1,2,4-triaminobenzenu - Google Patents

Pochodne 1,2,4-triaminobenzenu

Info

Publication number
PL377221A1
PL377221A1 PL377221A PL37722103A PL377221A1 PL 377221 A1 PL377221 A1 PL 377221A1 PL 377221 A PL377221 A PL 377221A PL 37722103 A PL37722103 A PL 37722103A PL 377221 A1 PL377221 A1 PL 377221A1
Authority
PL
Poland
Prior art keywords
nervous system
central nervous
treating disorders
derivatives useful
triaminobenzene derivatives
Prior art date
Application number
PL377221A
Other languages
English (en)
Polish (pl)
Inventor
Mario Rottländer
Andreas Ritzen
Noergaard Morten Bang
Nikolay Khanzhin
Tornoee Christian Wenzel
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL377221(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of PL377221A1 publication Critical patent/PL377221A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL377221A 2002-12-27 2003-12-18 Pochodne 1,2,4-triaminobenzenu PL377221A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200202012 2002-12-27

Publications (1)

Publication Number Publication Date
PL377221A1 true PL377221A1 (pl) 2006-01-23

Family

ID=35295526

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377221A PL377221A1 (pl) 2002-12-27 2003-12-18 Pochodne 1,2,4-triaminobenzenu

Country Status (17)

Country Link
KR (1) KR20050089862A (ru)
CN (1) CN100448867C (ru)
AR (1) AR042656A1 (ru)
BR (1) BR0317748A (ru)
CL (1) CL2003002748A1 (ru)
EA (1) EA008589B1 (ru)
HK (1) HK1088317A1 (ru)
IS (1) IS2649B (ru)
MY (1) MY139844A (ru)
NO (1) NO20053612L (ru)
PE (1) PE20041015A1 (ru)
PL (1) PL377221A1 (ru)
SI (1) SI1578740T1 (ru)
TW (1) TWI325414B (ru)
UA (1) UA79666C2 (ru)
UY (1) UY28151A1 (ru)
ZA (1) ZA200504565B (ru)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200259A1 (de) * 1992-01-08 1993-07-15 Asta Medica Ag Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
DE19539861A1 (de) * 1995-10-26 1997-04-30 Asta Medica Ag Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
GB9915414D0 (en) * 1999-07-01 1999-09-01 Glaxo Group Ltd Medical use
US6117900A (en) * 1999-09-27 2000-09-12 Asta Medica Aktiengesellschaft Use of retigabine for the treatment of neuropathic pain
US6589986B2 (en) * 2000-12-20 2003-07-08 Wyeth Methods of treating anxiety disorders

Also Published As

Publication number Publication date
TWI325414B (en) 2010-06-01
IS2649B (is) 2010-08-15
UA79666C2 (en) 2007-07-10
MY139844A (en) 2009-11-30
BR0317748A (pt) 2005-11-22
HK1088317A1 (en) 2006-11-03
SI1578740T1 (sl) 2007-08-31
NO20053612D0 (no) 2005-07-25
ZA200504565B (en) 2006-08-30
CN100448867C (zh) 2009-01-07
EA008589B1 (ru) 2007-06-29
AR042656A1 (es) 2005-06-29
UY28151A1 (es) 2004-07-30
NO20053612L (no) 2005-09-23
CN1732162A (zh) 2006-02-08
KR20050089862A (ko) 2005-09-08
CL2003002748A1 (es) 2005-04-08
PE20041015A1 (es) 2005-01-08
EA200501053A1 (ru) 2005-12-29
IS7856A (is) 2005-05-23
TW200413280A (en) 2004-08-01

Similar Documents

Publication Publication Date Title
EP1434801A4 (en) TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM
AU2003249983A8 (en) Piperidines useful for the treatment of central nervous system disorders
HK1078858A1 (en) Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders
IL176581A0 (en) Immunomodulatory compounds for the treatment of central nervous system disorders
SI1572215T1 (sl) Benzo(d)azepinski derivati za zdravljenje nevroloĺ kih motenj
IL175055A0 (en) Combinations useful for the treatment of neuronal disorders
MXPA03007960A (es) Compuestos y metodos para el tratamiento de desordenes urogenitales.
AU8187701A (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
AU2002212226A1 (en) Use of indole derivatives for treating illnesses of the central nervous system
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
AU2002356525A1 (en) Substituted amines for the treatment of neurological disorders
ZA200509169B (en) Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor
AU7388101A (en) Indole derivatives useful for the treatment of cns disorders
IS2172B (is) Indól afleiður sem eru nytsamlegar fyrir meðhöndlun á taugakerfistruflunum
MXPA03001472A (es) Compuestos para el tratamiento de trastornos adictivos.
ZA200504565B (en) 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system
WO2004048318A8 (en) Improved process for the preparation of 1,3-substituted indenes
SI1468686T1 (sl) S-metil-dihidro-ziprazidon za zdravljenje psihiatricnih motenj
IL153254A0 (en) Indole derivatives useful for the treatment of cns disorders
AU2003202255A8 (en) Compositions for treatment of central nervous system neoplasms, and methods of making and using the same
IL136949A0 (en) 1,4-diazacycloheptane derivatives for the treatment of neurological disorders
NO20012538D0 (no) Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet
AU2003228813A8 (en) Methods for treating neuronal disorders
GB0010496D0 (en) Treatment of conditions of the central nervous system
GB0326967D0 (en) Use of pyrimidine derivatives for the treatment of psychiatric disorders

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)